Evotec AG Reports Results of the First Nine Months of 2015
November 10, 2015 02:46 ET
|
Evotec AG
Strong Growth in Revenues and ProfitsThree Major EVT Innovate Deals ConcludedRevenue Guidance Raised on 15 September 2015 HAMBURG, Germany, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Evotec AG...
Evotec AG Increases Its Revenue Guidance for 2015
September 15, 2015 01:40 ET
|
Evotec AG
HAMBURG, Germany, Sept. 15, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it increases its financial guidance for the current...
Evotec to Present at Two Upcoming IR Conferences
September 10, 2015 09:33 ET
|
Evotec AG
HAMBURG, Germany, Sept. 10, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX, ISIN: DE0005664809) announced today that its CEO, Dr Werner Lanthaler, will present at the Morgan Stanley...
Evotec Enters Into Licence and Collaboration Agreement With Pfizer Inc. in Tissue Fibrosis
September 09, 2015 01:38 ET
|
Evotec AG
HAMBURG, Germany, Sept. 09, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it has signed an agreement on a four-year research collaboration with...
Evotec and CHDI Foundation Expand Ongoing Collaboration to Fight Huntington’s Disease Using Evotec’s Expanded Capabilities and Footprint
September 02, 2015 01:40 ET
|
Evotec AG
HAMBURG, Germany, Sept. 02, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced that CHDI Foundation, Inc. (“CHDI”) has extended and...
Evotec AG Reports Results of First Half of 2015
August 12, 2015 02:06 ET
|
Evotec AG
STRONG PERFORMANCE OF EVT EXECUTE SERVICES ACCELERATION OF EVT INNOVATE STRATEGY HAMBURG, Germany, Aug. 12, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX)...
Evotec, Apeiron Biologics and Sanofi Jointly Develop Novel Small Molecule-Based Cancer Immunotherapies
August 10, 2015 01:27 ET
|
Evotec AG
HAMBURG, Germany, Aug. 10, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) and Apeiron Biologics AG, a biotech company with a focus on immunological...
Sanofi and Evotec Align Forces to Develop Next Generation Therapies in Diabetes
August 07, 2015 01:14 ET
|
Evotec AG
Development of beta cell replacement therapyDiscovery and development of beta cell modulating drugsRisk-shared transaction exceeding € 300 m milestone potential and significant royalties for...
Evotec to Report First Half-Year 2015 Results on 12 August 2015
August 05, 2015 06:12 ET
|
Evotec AG
HAMBURG, Germany, Aug. 05, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) will report its financial results for the first half of 2015 on Wednesday, 12 August 2015. ...
Evotec Enters Innovative Research Initiative With Gladstone Institutes and Dolby Family Ventures in Alzheimer’s Disease
July 24, 2015 01:46 ET
|
Evotec AG
SAN FRANCISCO and HAMBURG, Germany, July 24, 2015 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt Stock Exchange:EVT) (TecDAX) (ISIN:DE0005664809) today announced that it has become part of a research...